LIFECORE BIOMEDICAL, INC. \DE\ cotiza a 6.42 USD y tiene una capitalización bursátil de $243M. Datos fundamentales de la SEC EDGAR con hasta 20 años de histórico, insiders, institucionales y valoración DCF.Más empresas del sector Salud
Lifecore Biomedical, Inc., together with its subsidiaries, operates as an integrated contract development and manufacturing organization that serves customers in the United States, Belgium, the Netherlands, and internationally. It provides services in the development, manufacture, aseptic fill, and finish of formulatio…
| Periodo | 2026-11 | 2026-08 | 2026-05 | 2026-03 |
|---|---|---|---|---|
| Real | — | $-0.19 | $-0.43 | $-0.16 |
| Estimado | $-0.31 | $-0.22 | $-0.29 | $-0.16 |
| Sorpresa | — | +13.6% | -48.3% | +0.0% |
| Métrica | LFCR | Mediana Sector | Δ |
|---|---|---|---|
| Gross Margin | 31.3% | 57.0% | -25.8% |
| Operating Margin | -13.4% | -38.6% | +25.2% |
| Net Margin | -30.0% | -33.6% | +3.5% |
| FCF Margin | -10.6% | -13.9% | +3.3% |
| ROE | -2898.0% | -40.4% | -2857.6% |
| ROA | -16.2% | -32.0% | +15.8% |
| Current Ratio | 2.84 | 2.84 | 0.00 |
| Debt / Equity | 97.63 | 0.28 | +97.35 |